The Management Services Organization (MSO)
How Private Equity Invests in Doctors Without Technically Employing Them
A dermatologist in Texas sells her practice to a private equity-backed company. But here’s the thing: in Texas (and most states), a corporation can’t technically employ a physician or own a medical practice. That’s the Corporate Practice of Medicine doctrine (CPOM).
So the PE firm doesn’t buy the medical practice. It buys (or creates) an MSO — a management company — that provides every non-clinical service the practice needs: billing, revenue cycle management, HR, IT, marketing, compliance, lease management, and purchasing. The medical practice remains a separate legal entity, technically physician-owned. But the MSO runs the business.
What It Is
An MSO provides administrative and operational services to physician practices while the physicians retain clinical ownership and decision-making authority. The MSO is the operational backbone; the physicians are the clinical entity.
Why It Exists
CPOM laws exist in most states to prevent corporations from interfering with physician judgment. The MSO model was designed to comply with these laws while allowing outside capital (especially private equity) to invest in the economics of physician practices.
The MSO captures value through management fees — typically 15–25% of the practice’s revenue, sometimes more. Since the MSO provides all the non-clinical infrastructure, it’s where the PE investment lives and where the returns are generated.
How It’s Organized
On paper, it looks like two separate entities. The Medical Practice (physician-owned) makes all clinical decisions: what to prescribe, when to refer, how to treat. The MSO (PE-owned or investor-owned) handles everything else: billing, staffing, technology, compliance, marketing, and lease negotiation.
In practice, the line between “operational” and “clinical” decision-making can blur. When the MSO controls scheduling templates, staffing ratios, supply purchasing, and revenue targets, it shapes the clinical environment even without making direct clinical decisions.
The Tradeoffs
The upside is resources. Independent physicians get capital for technology, marketing, and growth that they couldn’t access alone. Operations are professionalized. The physician is freed from the administrative burden of running a small business.
The downside is control. PE-backed MSOs are in the returns business. Management fees extract significant value. Long-term management agreements (often 20–30 years) can lock physicians into unfavorable arrangements. And when the MSO’s incentive to maximize margin collides with the physician’s obligation to patients, the physician doesn’t always win.
State attorneys general are increasingly scrutinizing aggressive MSO structures. The FTC’s action against US Anesthesia Partners and state investigations into PE-backed healthcare rollups signal growing regulatory risk.
The Bottom Line
The MSO is the legal architecture that allows private equity to participate in physician practice economics. It’s the reason a financial sponsor can “own” a dermatology chain, a dental group, or an emergency medicine company without technically employing a single doctor. Understanding this structure is essential for anyone trying to understand where the money flows in consolidated physician practices.